Abstract

Objective: Neuropathic pain arises from damage or pathological changes in the peripheral or central nervous system. The pain is difficult to treat as standard treatment with conventional analgesics doesn`t typically provide effective relief of pain.
 Methods: It was a one-year study of utilization and analysis of prescriptions for PNDs (Painful neuropathic disorders). The parameters evaluated were demographic profile of the patient (age and gender), type and etiology of PNDs, drug data (name of the group of drugs with individual drugs, mono or polytherapy, number of drugs per prescription, formulation) and associated adverse drug reactions (ADR) with the prescribed drug.
 Results: Maximum number of patients of PNDs resides in the age group of 18 – 35 yrs (41.2%) & more common in females. The most common PND encountered was painful diabetic neuropathy (43.9%) followed by cervical and lumbar radiculopathy, postherpetic neuralgia. 2942 drugs were prescribed in 1020 prescriptions out of which 96.8% were oral and 3.2% were topical formulations. Most frequently prescribed group of the drug was tricyclic antidepressants (27.3%) followed by anticonvulsants (25.3%). Polypharmacy was seen 89.7% as compared to monotherapy (10.3%). Only 132 ADRs of various types were seen. The most common organ system affected was the central nervous system followed by gastro intestinal systems. The most common drugs implicated for ADRs were TCAs (24.4%), anticonvulsants (16.6%), and Pregabeline (9.8%). There were no fatal adverse events. Mild to moderate ADRs included constipation, nausea, vomiting, drowsiness, dryness of mouth.
 Conclusions: The choice of drug depends on etiology of neuropathic pain, drug efficacy and availability and also on ADR profile.

Highlights

  • The most common drugs implicated for adverse drug reactions (ADR) were TCAs (24.4%), anticonvulsants (16.6%), and Pregabeline (9.8%)

  • The choice of drug depends on etiology of neuropathic pain, drug efficacy and availability and on ADR profile

  • I have published an original article in the International Journal of Pharmacy and Pharmaceutical Sciences in 2014

Read more

Summary

Introduction

Print ISSN: 2656-0097 | Online ISSN: 0975-1491 SUBHRANSU SEKHAR JENA1, MONALISA JENA2*, NIBEDITA PATRO3, SWATI MISHRA2, MAITREYEE PANDA3, MRUTUNJAY DASH4 Methods: It was a one-year study of utilization and analysis of prescriptions for PNDs (Painful neuropathic disorders).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call